Total Payments
$3,410
2023 Payments
$30.58
Companies
21
Transactions
225
Medicare Patients
701
Medicare Billing
$90,200
Payment Breakdown by Category
Food & Beverage$3,395 (99.6%)
Education$15.31 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,395 | 222 | 99.6% |
| Education | $15.31 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,208 | 71 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $435.31 | 34 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $408.86 | 25 | $0 (2021) |
| PFIZER INC. | $319.68 | 24 | $0 (2020) |
| AbbVie Inc. | $162.61 | 10 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $140.64 | 11 | $0 (2017) |
| GlaxoSmithKline, LLC. | $132.89 | 8 | $0 (2020) |
| Allergan, Inc. | $119.78 | 8 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $115.49 | 10 | $0 (2017) |
| Lilly USA, LLC | $72.05 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.58 | 2 | AstraZeneca Pharmaceuticals LP ($30.58) |
| 2022 | $23.64 | 1 | IDORSIA PHARMACEUTICALS US INC ($23.64) |
| 2021 | $125.08 | 7 | AstraZeneca Pharmaceuticals LP ($51.58) |
| 2020 | $508.72 | 30 | AstraZeneca Pharmaceuticals LP ($177.71) |
| 2019 | $645.97 | 43 | AstraZeneca Pharmaceuticals LP ($265.28) |
| 2018 | $776.65 | 51 | AstraZeneca Pharmaceuticals LP ($230.01) |
| 2017 | $1,299 | 91 | AstraZeneca Pharmaceuticals LP ($452.88) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Respiratory | ||||||
| 04/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: INSOMNIA | ||||||
| 08/18/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Gastroenterology | ||||||
| 07/09/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Respiratory | ||||||
| 05/25/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: DIABETES | ||||||
| 04/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: DIABETES | ||||||
| 04/13/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Respiratory | ||||||
| 12/16/2020 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: DIABETES | ||||||
| 10/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: DIABETES | ||||||
| 10/02/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Respiratory | ||||||
| 09/15/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLUJAN | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/31/2020 | Sun Pharmaceutical Industries Inc. | DRIZALMA SPRINKLE (Drug), KAPSPARGO, EZALLOR SPRINKLE | Food and Beverage | Cash or cash equivalent | $19.59 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/25/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Respiratory | ||||||
| 08/14/2020 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/10/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/20/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuroscience | ||||||
| 07/13/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 91 | 117 | $16,741 | $7,853 |
| 2022 | 4 | 202 | 494 | $44,874 | $26,509 |
| 2021 | 4 | 215 | 523 | $46,293 | $29,051 |
| 2020 | 3 | 193 | 386 | $45,273 | $26,787 |
Total Patients
701
Total Services
1,520
Medicare Billing
$90,200
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 88 | $13,464 | $6,887 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 29 | $3,277 | $965.53 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 88 | 190 | $29,070 | $18,586 | 63.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 132 | $14,931 | $7,655 | 51.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 29 | $493.00 | $258.18 | 52.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 14 | 143 | $380.00 | $9.01 | 2.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 82 | 166 | $25,398 | $17,579 | 69.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 178 | $20,114 | $11,246 | 55.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 20 | 23 | $391.00 | $209.80 | 53.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 19 | 156 | $390.00 | $16.40 | 4.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 114 | 260 | $29,395 | $16,686 | 56.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 62 | 101 | $15,453 | $9,894 | 64.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 17 | 25 | $425.00 | $207.20 | 48.8% |
About Dr. Barry Moak, M.D
Dr. Barry Moak, M.D is a Family Medicine healthcare provider based in Abilene, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063415677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Moak, M.D has received a total of $3,410 in payments from pharmaceutical and medical device companies, with $30.58 received in 2023. These payments were reported across 225 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,395).
As a Medicare-enrolled provider, Moak has provided services to 701 Medicare beneficiaries, totaling 1,520 services with total Medicare billing of $90,200. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Abilene, TX
- Active Since 05/27/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1063415677
Products in Payments
- FARXIGA (Drug) $639.95
- JARDIANCE (Drug) $424.40
- JANUVIA (Drug) $333.30
- SYMBICORT (Drug) $303.70
- BEVESPI AEROSPHERE (Drug) $168.67
- VIAGRA (Drug) $146.59
- CHANTIX (Drug) $103.92
- Synthroid (Drug) $92.42
- NUEDEXTA (Drug) $72.05
- LYRICA (Drug) $69.17
- Trintellix (Drug) $68.62
- ONZETRA Xsail (Drug) $68.59
- LINZESS (Drug) $59.14
- BREZTRI (Drug) $55.88
- ANORO ELLIPTA (Drug) $55.08
- Movantik (Drug) $53.17
- ANORO (Drug) $50.51
- Uloric (Drug) $48.93
- Vascepa (Drug) $41.34
- NAMZARIC (Drug) $35.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Abilene
Dr. Martha Walke, M.d, M.D
Family Medicine — Payments: $311,225
Family Medicine $311,225
Dr. Indira Maharaj-Mikiel, M.d, M.D
Family Medicine — Payments: $36,046
Family Medicine $36,046
David Randell, Do, DO
Family Medicine — Payments: $23,551
Family Medicine $23,551
Dr. David Longley, D.o, D.O
Family Medicine — Payments: $16,758
Family Medicine $16,758
Dr. Kevin Finley, D.o, D.O
Family Medicine — Payments: $16,391
Family Medicine $16,391
Sambhitab Salvi, Md, MD
Family Medicine — Payments: $14,838
Family Medicine $14,838